BeStock  
Markets › Compare › NUVB vs NTLA

NUVB vs NTLA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NUVB · Nuvation Bio$3.80 ▼ 0.26%
NTLA · Intellia Therapeutics$10.00 ▲ 5.04%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4187132178223Nov 24, '25May 26, '26Nov 20, '26
  • NUVB -48.7%
  • NTLA +19.8%

Head to head

MetricNUVBNTLA
Price$3.80$10.00
Change today▼ 0.26%▲ 5.04%
Market cap$1.34B$1.40B
Return, 3 months-43.8%-20.4%
Return, year to date-57.6%+11.2%
Return, 1 year-45.6%+21.8%
P/E (TTM)––
P/B5.92.3
P/E percentile vs own 5y23rd78th
Dividend yield––
Revenue growth (YoY, latest qtr)+242.6%-48.0%
Net profit growth (YoY)+24.9%-25.8%
Gross margin85.8%–
Operating margin-61.2%-821.2%
Net margin-67.4%-805.7%
Return on equity-49.1%-62.6%
Analyst target vs. price+258.7%+92.0%
Analyst buy share100%36%
RSI (14)3141
30-day volatility57.5%77.8%
Max drawdown, 1 year-60.4%-46.6%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NTLA is the largest of the group by market value.
  • NTLA has returned the most over the past year.
  • NUVB is growing revenue fastest.
  • NUVB keeps the most profit per dollar of sales.
  • NUVB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top